Olema Oncology Company

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.
Industry: General Health Care
Headquarters: San Francisco, California, United States
Founded Date: 2007-01-01
Funding Status: IPO
Total Funding: $145 000 000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-10-01
Last Funding Type: Series C

Visit Website
https://twitter.com/olemapharma
Register and Claim Ownership